Valuation : G MEDPAR

Market Cap 7L 6L 6L 5L 10L 6.88Cr 10.03L 69.43L 26.83L 3.5Cr 27.15L 26.56L 11Cr P/E 2021
-1.29x
P/E 2022 -0.17x
Enterprise Value 25.2L 21.68L 20.42L 18.6L 34.81L 24Cr 34.95L 2.42Cr 93.53L 12Cr 94.63L 92.57L 39Cr EV / Sales 2021
4.92x
EV / Sales 2022 1.15x
Free-Float
-
Yield 2021 *
-
Yield 2022 -
1 day+9,900.00%
Current month+9,900.00%
Current year-50.00%
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0.03
3 years 0
Extreme 1.0E-6
0.09
5 years 0
Extreme 1.0E-6
235.9
10 years 0
Extreme 1.0E-6
235.9
Manager TitleAgeSince
Chief Executive Officer 75 03/10/2014
Director of Finance/CFO 46 31/07/2022
Chief Tech/Sci/R&D Officer 56 01/12/2017
Director TitleAgeSince
Director/Board Member 75 03/10/2014
Chairman 72 21/08/2014
Director/Board Member 76 24/02/2017
Date Insider Type Main position Quantity % Market Cap. Importance
31/03/23
AWM Investment Co., Inc.
SellCompany 7,37,500 37.5554%
31/03/23
AWM Investment Co., Inc.
OtherCompany 14,37,500 73.2011%

Financials

2021 2022
Net sales 50.58L 43.52L 40.98L 37.34L 69.87L 48Cr 70.14L 4.86Cr 1.88Cr 25Cr 1.9Cr 1.86Cr 78Cr 44.2L 38.03L 35.81L 32.63L 61.05L 42Cr 61.3L 4.24Cr 1.64Cr 21Cr 1.66Cr 1.62Cr 68Cr
Net income -1.48Cr -1.27Cr -1.2Cr -1.09Cr -2.04Cr -140.43Cr -2.05Cr -14Cr -5.48Cr -72Cr -5.54Cr -5.42Cr -226.65Cr -1.35Cr -1.16Cr -1.1Cr -99.82L -1.87Cr -128.66Cr -1.88Cr -13Cr -5.02Cr -66Cr -5.08Cr -4.97Cr -207.65Cr
Net Debt 24.08L 20.72L 19.51L 17.78L 33.26L 23Cr 33.39L 2.31Cr 89.37L 12Cr 90.42L 88.46L 37Cr 17.97L 15.46L 14.56L 13.27L 24.82L 17Cr 24.92L 1.73Cr 66.69L 8.71Cr 67.48L 66.01L 28Cr
Logo G MEDPAR
G Medical Innovations Holdings Ltd. is a mobile health (mHealth) and e-health company. The Company is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. It also develops wireless vital signs monitoring systems.
Employees
-
Sector
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. GMVDF Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!